Actor Sonu Sood helps seven-month-old Safan Ali receive a liver
transplant at Aster Medcity, Kochi through the Second Chance Initiative
- The Second Chance initiative was launched by Bollywood Actor Sonu Sood in partnership with Aster Volunteers, CSR arm of Aster DM Healthcare to support underprivileged children in need of liver transplant
- Safan Ali is the first child to benefit from the liver transplant programme which would support 50 children in the first phase.
- Children from underprivileged families can seek to undergo the liver transplant at Aster CMI and Aster RV Hospitals in Bangalore, and Aster Medcity and Aster MIMS Hospital Calicut in Kerala, India. Families in need can seek further information by Whatsapp on these 24 x7 helplines: 8113078000, 9656000601.
Mumbai, July 21, 2022: The Second Chance Initiative launched by Aster Volunteers in
association with Bollywood Actor Sonu Sood treated its first patient – seven-month-old
Mohammed Safan Ali. His mother was the donor and he underwent the liver transplant at Aster Medcity Hospital in Kochi, India.
Safan Ali was brought to Aster when he was four months old. He was diagnosed with Biliary
Atresia, a rare condition where the bile ducts or the tube that connects the liver to the intestine does not develop. This results in jaundice and yellowish discolouration of the eyes, which subsequently leads to liver failure. Following a failed surgical intervention in his native
Karimnagar, Telangana, he progressed to have severe jaundice and cirrhosis which necessitated a liver transplant. It was then through the help of Sonu Sood that the patient reached Aster Medcity in Kochi and underwent a successful liver transplant procedure.
Talking about Safan, Dr. Mathew Jacob, Lead Senior Consultant at Aster Medcity Hospital, said, “When Safan came to us, he was deeply jaundiced, malnourished, and had developmental delays. We counseled the parents on the nature of his illness and the immediate need for liver transplantation. He was then admitted for a pre-transplant workup. Despite heavy odds related to the child’s age and underdeveloped physique, the surgery was completed without a hitch. He has made a good recovery, is free of jaundice, and is thriving well.”
The surgical procedure was performed by a select team of surgeons including Dr. Charles
Panackel, Senior Consultant Hepatologist, Dr. Geetha Mammayil, Paediatric Gastroenterology, Dr. Sudheer Muhammed M, Consultant Surgeon, Dr. Biju Chandran, Consultant Surgeon.
Speaking on the initiative Dr. Azad Moopen, Founder Chairman & Managing Director, Aster DM Healthcare said, “Liver Transplant is a prohibitively expensive lifesaving quaternary treatment done only at a very few hospitals in the country. The Integrated Liver Transplant team at Aster has performed one among the largest series of Paediatric liver transplants in the country, which is the only option for survival for most cases. The humongous expenses for this, though it is the lowest in India at Aster, is beyond the means of most parents. We are glad that with the Second Chance initiative for Liver Transplant done in association with Shri. Sonu Sood, we have been able to save Mohammed Safan Ali from the clutches of death at a young age.”
Mr. Sonu Sood, an actor by profession, has chosen to commit unstinted patronage to the
Second Chance initiative which is set to benefit 49 more children from low-income families.
Following the announcement of the initiative, many adult patients have also stepped forward
to seek support.
“India has taken huge strides in the advancement of medical care but the access of the same is still miles away for patients like Safan Ali and his family, and mostly because of the high cost. Through this association with Second Chance initiative, we hope to give life to more patients like Safan Ali,” said Bollywood Actor Sonu Sood.
Aster Hospitals’ newly launched Multi-Organ Transplant facilities are multi-institutional and
multidisciplinary centres designed to provide the best transplant experience. The centres are
manned by skilled teams of surgeons with technical expertise in performing different types of
transplants including Liver, Kidney, Heart, Lung, Cornea and Bone Marrow. The centre at Aster Medcity is one of the largest paediatric liver transplant programmes in South India, supporting comprehensive care for liver diseases in children. Empowered with vast experience in hepato- pancreato biliary and abdominal multi-organ transplant surgeries, the team has completed over
500 successful Liver Transplant Surgeries within the Aster Hospitals in India.
About Aster DM Healthcare
Aster DM Healthcare Limited is one of the largest private healthcare service providers operating in GCC and in India. With an inherent emphasis on clinical excellence, we are one of the few entities in the world with a strong presence across primary, secondary, tertiary, and quaternary healthcare through our 29 hospitals, 120 clinics, 371 pharmacies and 114 labs & patient experience centres in seven countries, including India. We have over 25,800 plus dedicated staff including 3,200+ doctors and 7,000+
nurses across the geographies that we are present in, delivering a simple yet strong promise to our different stakeholders: "We'll treat you well." We reach out to all economic segments in the GCC states through our differentiated healthcare services across the "Aster", "Medcare" and "Access" brands.
For more information about us, please contact:
PR & Communications
Aster DM Healthcare
Tel: +91 9819288911
Email: [email protected]
Tel: +91 9820177907
Email: [email protected]
Certain statements in this document that are not historical facts are forward looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local, political or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. Aster DM Healthcare will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.